Table 1 Myeloid-specific ikkβ gene deletion ameliorates a subsequent encephalogenic challenge
Group | Incidence (%) | Mean day of onset (± SEM) | Maximal clinical score (± SEM) | Sun of clinical score (± SEM) | Mortality (%) | |
|---|---|---|---|---|---|---|
PBS | Wild type | 3/3 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0 |
LysM-Cre/Ikkβ F/F | 3/3 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0 | |
MOG | Wild type | 7/7 | 7.6 ± 0.7 | 3.4 ± 0.2# | 64.1 ± 1.7# | 0 |
LysM-Cre/Ikkβ F/F | 7/7 | 10.2 ± 0.5 | 2.6 ± 0.2* | 17.3 ± 3.0* | 0 |